CEBPA double mutations associated with ABO antigen weakness in hematologic diseases

Area of Science:

• Hematology
• Genetics
• Transfusion Medicine

Background:

• ABO antigen weakness is a rare finding in blood typing.
• Its precise causes, particularly genetic links, remain unclear.
• Hematologic diseases are suspected contributors.

Purpose of the Study:

• To investigate the association between ABO antigen weakness and hematologic diseases.
• To identify novel genetic factors contributing to ABO antigen weakness.
• To reconfirm existing associations using extensive data.

Main Methods:

• Analysis of ABO typing and genetic data over 7 years.
• Statistical analysis including odds ratios (OR) and confidence intervals (CI).
• Identification of candidate genes through genetic analysis.

Main Results:

• Confirmed association between ABO antigen weakness and acute myeloid leukemia (OR, 2.55) and myelodysplastic syndrome (OR, 6.94).
• Identified novel candidate genes: CEBPA (OR, 43.70), NRAS (OR, 3.37), U2AF1 (OR, 8.12), and PTPN11 (OR, 4.52).
• CEBPA double mutations showed a strong association (80.0% prevalence in affected individuals).

Conclusions:

• New genetic factors, notably CEBPA mutations, are significantly associated with ABO antigen weakness.
• The study strengthens the link between specific hematologic malignancies and weakened ABO antigens.
• Further research into these genetic associations is warranted.